Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giorgia Nardo
Observed names:
G Nardo,
G. Nardo
Institution:
Istituto Oncologico Veneto
Observed institutions:
University of Verona,
University of Padua,
University Medical Center of the Johannes Gutenberg University Mainz,
MultiMedica,
Institut Català d'Oncologia,
Istituto Oncologico Veneto,
University of Brescia
show all 7
ORCID:
0000-0003-0233-1324
Observed ORCID:
0000-0003-0233-1324
OpenAlex ID:
A5040151622
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
2014
·
Anna Pastò
, Chiara Bellio
, et al.
·
Oncotarget
·
298
PDF
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
2018
·
Massimiliano Cadamuro
, Simone Brivio
, et al.
·
Journal of Hepatology
·
198
PDF
Platelet-Derived Growth Factor-D And Rho Gtpases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
2013
·
Massimiliano Cadamuro
, Giorgia Nardo
, et al.
·
Hepatology
·
179
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization
2011
·
Luca Fabris
, Massimiliano Cadamuro
, et al.
·
Hepatology
·
86
PDF
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization
2011
·
Giorgia Nardo
, Elena Favaro
, et al.
·
Cancer Research
·
75
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2014
·
Matteo Curtarello
, Elisabetta Zulato
, et al.
·
Cancer Research
·
74
RNA interference: Implications for cancer treatment
2007
·
Massimo Masiero
, Giorgia Nardo
, et al.
·
Molecular Aspects of Medicine
·
71
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
2011
·
Daria Leali
, Patrizia Alessi
, et al.
·
Molecular Cancer Therapeutics
·
59
PDF
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients
2013
·
Elisabetta Rossi
, Massimo Rugge
, et al.
·
Oncoscience
·
57
PDF
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
2017
·
Laura Bonanno
, Angela De Paoli
, et al.
·
Clinical Cancer Research
·
53
Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma
2016
·
Massimiliano Cadamuro
, Gaia Spagnuolo
, et al.
·
Cancer Research
·
52
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.
2010
·
Laura Bonanno
, Marco Schiavon
, et al.
·
PubMed
·
50
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
2021
·
Alberto Pavan
, Andrea Boscolo Bragadin
, et al.
·
Translational Lung Cancer Research
·
47
PDF
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
2020
·
Elisabetta Zulato
, Ilaria Attili
, et al.
·
British Journal of Cancer
·
47
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation
2018
·
E. Zulato
, F. Ciccarese
, et al.
·
Biochemical Pharmacology
·
42
Hypoxia Inducible Factor-1α Inactivation Unveils a Link between Tumor Cell Metabolism and Hypoxia-Induced Cell Death
2008
·
Elena Favaro
, Giorgia Nardo
, et al.
·
American Journal Of Pathology
·
42
PDF
Intestinal Microflora as an Alternative Metabolic Source of Estrogens in Women with Uterine Leiomyoma and Breast Cancer
1990
·
E. Bertazzoni Minelli
, A. M. Beghini
, et al.
·
Annals of the New York Academy of Sciences
·
39
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy
2019
·
Alessandro Dal Maso
, Martina Lorenzi
, et al.
·
Clinical Lung Cancer
·
26
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
2022
·
Elisabetta Zulato
, Paola Del Bianco
, et al.
·
British Journal of Cancer
·
25
PDF
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients
2021
·
Elisabetta Zulato
, Valeria Tosello
, et al.
·
Diagnostics
·
18
PDF
Metabolic effects of anti-angiogenic therapy in tumors
2012
·
Elisabetta Zulato
, Matteo Curtarello
, et al.
·
Biochimie
·
18
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
2020
·
Ilaria Piga
, Martina Verza
, et al.
·
Frontiers in Oncology
·
17
PDF
Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth
2018
·
Elisabetta Zulato
, Francesco Ciccarese
, et al.
·
Frontiers in Oncology
·
16
PDF
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
2021
·
Giorgia Nardo
, Jessica Carlet
, et al.
·
Frontiers in Oncology
·
14
PDF
Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system
2015
·
Kristina Goetze
, Christian G. Fabian
, et al.
·
Cellular Oncology
·
14
Show more works
View as search
Works count:
91
Citation count:
1,713
H-index:
19
I10-index:
29
Year
Topic
Type
